Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00592514 · ClinicalTrials.gov registry record
Thyroid Dysfunction in Head and Neck Surgery Patients
A clinical trial, sponsored by University of Arkansas.
- Completed
- Registry status
- 14
- Enrollment target
NCT00592514: Completed study, sponsored by University of Arkansas.
NCT00592514 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00592514 has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
Specific Aim I: Determine absorption of iodine after oropharyngeal application of povidone-iodine 10% solution when used in head and neck surgery involving the upper aero-digestive tract. Specific Aim II: Measurement of iodine induced changes in thyroid function.
Primary Outcome
Specific Aim I: Determine absorption of iodine after oropharyngeal application of povidone-iodine 10% solution when used in head and neck surgery involving the upper aero-digestive tract.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2005-07 |
| Est. Completion | 2008-07 |
What the finished NCT00592514 record still lists
NCT00592514 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00592514 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00592514 about?
NCT00592514 is a clinical study titled "Thyroid Dysfunction in Head and Neck Surgery Patients". Specific Aim I: Determine absorption of iodine after oropharyngeal application of povidone-iodine 10% solution when used in head and neck surgery involving the upper aero-digestive tract. Specific Aim II: Measurement of iodine induced changes in thyroid function.
What is the current status of trial NCT00592514?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2005-07. Estimated completion is 2008-07.
Who is sponsoring clinical trial NCT00592514?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia